EuroPCR 2017: Xeltis' Regenerated Heart Valve Shows Promising Early Preclinical Data

 
• By Catherine Longworth
  
Anatomy of Human Heart
Xeltis presented positive early data from preclinical studies at EuroPCR in Paris • Source: Shutterstock

More from Startups & SMEs

More from Business